Short answer · Medically reviewed summary · Last updated: 2026-04-07
Treatment for Sturge Weber Syndrome is focused on managing symptoms through a multidisciplinary approach, as there is currently no cure for the underlying vascular malformation. First-Line Medical Management Management of Sturge Weber Syndrome typically begins with controlling seizures and managing glaucoma. For seizures, neurologists often prescribe anti-seizure medications (ASMs) such as levetiracetam (Keppra), oxcarbazepine (Trileptal), or valproate (Depakene).
5 people with Sturge Weber Syndrome have shared their first-person experience on this question at DiseaseMaps.
Treatment for Sturge Weber Syndrome is focused on managing symptoms through a multidisciplinary approach, as there is currently no cure for the underlying vascular malformation.
Management of Sturge Weber Syndrome typically begins with controlling seizures and managing glaucoma. For seizures, neurologists often prescribe anti-seizure medications (ASMs) such as levetiracetam (Keppra), oxcarbazepine (Trileptal), or valproate (Depakene). When seizures become refractory to medication, epilepsy surgery may be considered to improve long-term outcomes.
Beyond medication, Sturge Weber Syndrome requires proactive dermatological and developmental care. Pulsed dye laser (PDL) therapy is the gold standard for treating the facial port-wine birthmark to reduce its size and intensity. Physical therapy and occupational therapy are essential for patients experiencing motor delays or hemiparesis, while specialized educational support is often necessary to address cognitive or learning challenges.
Because Sturge Weber Syndrome affects multiple systems, care must be personalized by a dedicated team. This team typically includes a pediatric neurologist (for epilepsy), an ophthalmologist (for glaucoma monitoring), a dermatologist (for vascular birthmark management), and a neurosurgeon. Genetic counseling is also recommended to discuss the somatic nature of the GNAQ gene mutation, which is not typically inherited.
Current clinical research is exploring the use of low-dose aspirin to potentially improve cerebral blood flow and prevent stroke-like episodes in patients with Sturge Weber Syndrome. Clinical trials are ongoing to better understand the efficacy of such preventative therapies, though evidence is still evolving.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read here.